Open AccessSynergistic combination cancer therapy based in lectin-targeted pH-responsive mesoporous silica nanoparticles
Author(s) -
Mart�nez-Carmona Marina,
Colilla Montserrat,
Lozano Daniel,
Vallet-Reg� Mar�a
Publication year - 2016
Publication title -
frontiers in bioengineering and biotechnology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.081
H-Index - 44
ISSN - 2296-4185
DOI - 10.3389/conf.fbioe.2016.01.01556
Subject(s) - mesoporous silica , nanocarriers , nanomedicine , nanotechnology , chemistry , drug delivery , nanoparticle , targeted therapy , doxorubicin , cancer cell , cytotoxic t cell , cancer research , cancer , pharmacology , materials science , mesoporous material , medicine , chemotherapy , biochemistry , catalysis , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom